Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Study of Adjuvant Therapy With Tamoxifen vs Endocrine Ablation vs Tamoxifen Plus Endocrine Ablation vs No Adjuvant Therapy in Patients Under Age 50 With Operable Breast Cancer

NCT00002460 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00002460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Study of Adjuvant Therapy With Tamoxifen vs Endocrine Ablation vs Tamoxifen Plus Endocrine Ablation vs No Adjuvant Therapy in Patients Under Age 50 With Operable Breast Cancer
Lead sponsor
Cancer Research UK
Phase
Phase 3
Overall status
Unknown status
Start date
September 30, 1987
Completion date
Not reported
Enrollment
Not reported
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer